Martek Biosciences
Executive Summary
Initial public offering of 2 mil. shares of common stock priced at $7 per share commences Nov. 23; Hambrecht & Quist, Bear Stearns, and Salomon Brothers are underwriters. Martek, based in Columbia, Md., is developing microalgae-derived nutritional, diagnostic and pharmaceutical products.